经导管主动脉瓣植入术后肾素-血管紧张素抑制剂的疗效 - Suppr

Outcomes of renin-angiotensin inhibitors following transcatheter aortic valve implantation.

作者信息

Hosseinpour Alireza, Gupta Rahul

机构信息

School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Lehigh Valley Heart Institute, Lehigh Valley Health Network, Allentown, Pennsylvania, USA.

出版信息

Clin Cardiol. 2024 Feb;47(2):e24187. doi: 10.1002/clc.24187. Epub 2023 Nov 7.

DOI:10.1002/clc.24187

PMID:37933892

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10826235/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c88c/10826235/af3c795665f2/CLC-47-e24187-g001.jpg

相似文献

Outcomes of renin-angiotensin inhibitors following transcatheter aortic valve implantation.

Clin Cardiol. 2024 Feb;47(2):e24187. doi: 10.1002/clc.24187. Epub 2023 Nov 7.

Transcatheter aortic valve implantation for low-risk aortic stenosis: are we ready?

Eur J Cardiothorac Surg. 2020 Mar 1;57(3):413-417. doi: 10.1093/ejcts/ezz372.

Moderate aortic stenosis: The next frontier of transcatheter aortic valve implantation?

Arch Cardiovasc Dis. 2023 Jun-Jul;116(6-7):295-297. doi: 10.1016/j.acvd.2023.05.005. Epub 2023 Jun 9.

Valve-in-Valve Transcatheter Aortic Valve Replacement Following 2 Surgical Aortic Valve Replacements.

Circ Cardiovasc Interv. 2023 Nov;16(11):e013305. doi: 10.1161/CIRCINTERVENTIONS.123.013305. Epub 2023 Nov 21.

Editorial commentary: Selection of transcatheter heart valves: The plethora of device-specific, anatomic-specific and patient-specific aspects for optimal results in transcatheter aortic valve replacement.

Trends Cardiovasc Med. 2022 Nov;32(8):523-524. doi: 10.1016/j.tcm.2021.10.003. Epub 2021 Oct 19.

Trends and outcomes in transcatheter aortic valve implantation: evolution of a revolution.

Acta Cardiol. 2022 Dec;77(10):984-985. doi: 10.1080/00015385.2022.2129181. Epub 2022 Nov 8.

Advancing Transcatheter Aortic Valve Replacement to the Frontiers of Lifetime Valve Management: Deliberations From the OBSERVANT II Trial.

Circ Cardiovasc Interv. 2022 Dec;15(12):e012607. doi: 10.1161/CIRCINTERVENTIONS.122.012607. Epub 2022 Dec 9.

Technical Considerations for Transcatheter Aortic Valve Replacement With the Navitor Transcatheter Heart Valve.

JACC Cardiovasc Interv. 2021 Oct 11;14(19):e259-e261. doi: 10.1016/j.jcin.2021.06.034. Epub 2021 Sep 15.

The 20-year "imaging saga" for transcatheter aortic valve implantation: A viewpoint.

Arch Cardiovasc Dis. 2022 Apr;115(4):225-230. doi: 10.1016/j.acvd.2022.04.002. Epub 2022 Apr 26.

Commentary: Surgical aortic valve replacement after transcatheter aortic valve replacement: Is it time to reconsider the lifelong management?

J Thorac Cardiovasc Surg. 2023 Jun;165(6):2024-2025. doi: 10.1016/j.jtcvs.2021.10.035. Epub 2021 Oct 29.

本文引用的文献

Association of ACEI/ARB and statin prescribing patterns with mortality after Transcatheter Aortic Valve Replacement (TAVR): Findings from real-world claims data.

Am Heart J. 2023 Apr;258:27-37. doi: 10.1016/j.ahj.2022.12.012. Epub 2022 Dec 31.

The clinical outcomes of reni-angiotensin system inhibitors for patients after transcatheter aortic valve replacement: A systematic review and meta-analysis.

Front Cardiovasc Med. 2022 Aug 11;9:963731. doi: 10.3389/fcvm.2022.963731. eCollection 2022.

Effects of renin-angiotensin system inhibitor type and dosage on survival after transcatheter aortic valve implantation.

Eur Heart J Cardiovasc Pharmacother. 2022 Dec 2;8(8):815-824. doi: 10.1093/ehjcvp/pvac027.

Optimal Medical Therapy Following Transcatheter Aortic Valve Implantation.

Am J Cardiol. 2021 Feb 15;141:62-71. doi: 10.1016/j.amjcard.2020.11.010. Epub 2020 Nov 19.

Dose-Dependent Effect of Renin-Angiotensin System Blockade Following Transcatheter Aortic Valve Replacement.

Can J Cardiol. 2021 Mar;37(3):443-449. doi: 10.1016/j.cjca.2020.08.014. Epub 2020 Aug 22.

Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries.

Eur Heart J. 2020 Feb 21;41(8):943-954. doi: 10.1093/eurheartj/ehz769.

Renin-angiotensin system blockade after transcatheter aortic valve replacement (TAVR) improves intermediate survival.

J Cardiovasc Thorac Res. 2019;11(3):176-181. doi: 10.15171/jcvtr.2019.30. Epub 2019 Aug 13.

Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement.

J Am Coll Cardiol. 2019 Aug 6;74(5):631-641. doi: 10.1016/j.jacc.2019.05.055.

Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement.

JAMA. 2018 Dec 4;320(21):2231-2241. doi: 10.1001/jama.2018.18077.

Renin-angiotensin system blockade therapy after transcatheter aortic valve implantation.

Heart. 2018 Apr;104(8):644-651. doi: 10.1136/heartjnl-2017-311738. Epub 2017 Oct 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Outcomes of renin-angiotensin inhibitors following transcatheter aortic valve implantation.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献